Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
28 October 2021
The Executive Director of Sopharma met with Vice President of Vietnam Mrs. Vo Thi Anh Xuan
Financial News
20 January 2025
Sales revenues for December 2024
15 January 2025
Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
20 December 2024
Decision on additional contribution to the capital of Sopharma Rus OOO
Financial Highlights 31 March, 2022
397 570
BGN '000 Revenue
34 368
BGN '000 EBITDA
21 827
BGN '000 Revenue from operating profit
22 560
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
30 January 2025
Publication of Preliminary Annual Individual financial statements for 2024
3 March 2025
Consolidated financial statements for Q4 of 2024

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A